药品集中采购政策旨在减轻患者药品费用负担,但实施效果与预期存在差距。公众参与药品集中采购政策制定对于确保政策的公正性和有效性至关重要,但目前公众参与的需求未得到满足。通过进一步探讨困境的成因,提出了完善参与机制;加快信息公开;提升组织化;加强监督和评估的公众参与路径。期望通过这些措施,促进政府对公众药品需求的精准把握,提升政策决策的科学性与有效性,最终实现药品供应的优化和药品费用的合理控制。The centralized drug procurement policy aims to reduce the burden of drug costs on patients, but there is a gap between its implementation and expectations. Public participation in the formulation of centralized drug purchasing policy is crucial to ensure the fairness and effectiveness of the policy, but the demand for public participation is currently unmet. By further exploring the causes of the dilemma, the public participation ways of improving the participation mechanism, accelerating information disclosure, and improving organization are proposed. It is expected that these measures will promote the government’s accurate grasp of the public’s demand for medicines, improve the science and effectiveness of policy-making, and ultimately achieve the optimization of drug supply and the reasonable control of drug costs.
